Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements

Jan B. Egan, Michael T. Barrett, Mia D. Champion, Sumit Middha, Elizabeth Lenkiewicz, Lisa Evers, Princy Francis, Jessica Schmidt, Chang Xin Shi, Scott Van Wier, Sandra Badar, Gregory Ahmann, K. Martin Kortuem, Nicole J. Boczek, Rafael Fonseca, David W. Craig, John D. Carpten, Mitesh J. Borad, A. Keith Stewart

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Liposarcoma is the most common soft tissue sarcoma, but little is known about the genomic basis of this disease. Given the low cell content of this tumor type, we utilized flow cytometry to isolate the diploid normal and aneuploid tumor populations from a well-differentiated liposarcoma prior to array comparative genomic hybridization and whole genome sequencing. This work revealed massive highly focal amplifications throughout the aneuploid tumor genome including MDM2, a gene that has previously been found to be amplified in well-differentiated liposarcoma. Structural analysis revealed massive rearrangement of chromosome 12 and 11 gene fusions, some of which may be part of double minute chromosomes commonly present in well-differentiated liposarcoma. We identified a hotspot of genomic instability localized to a region of chromosome 12 that includes a highly conserved, putative L1 retrotransposon element, LOC100507498 which resides within a gene cluster (NAV3, SYT1, PAWR) where 6 of the 11 fusion events occurred. Interestingly, a potential gene fusion was also identified in amplified DDR2, which is a potential therapeutic target of kinase inhibitors such as dastinib, that are not routinely used in the treatment of patients with liposarcoma. Furthermore, 7 somatic, damaging single nucleotide variants have also been identified, including D125N in the PTPRQ protein. In conclusion, this work is the first to report the entire genome of a well-differentiated liposarcoma with novel chromosomal rearrangements associated with amplification of therapeutically targetable genes such as MDM2 and DDR2.

Original languageEnglish (US)
Article numbere87113
JournalPloS one
Volume9
Issue number2
DOIs
StatePublished - Feb 5 2014

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements'. Together they form a unique fingerprint.

  • Cite this

    Egan, J. B., Barrett, M. T., Champion, M. D., Middha, S., Lenkiewicz, E., Evers, L., Francis, P., Schmidt, J., Shi, C. X., Van Wier, S., Badar, S., Ahmann, G., Kortuem, K. M., Boczek, N. J., Fonseca, R., Craig, D. W., Carpten, J. D., Borad, M. J., & Stewart, A. K. (2014). Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. PloS one, 9(2), [e87113]. https://doi.org/10.1371/journal.pone.0087113